Radiotherapy is superior to transarterial chemoembolization as adjuvant therapy after narrow-margin hepatectomy in patients with hepatocellular carcinoma: A single-center prospective randomized study-Reference-Cited by-同舟云学术

Radiotherapy is superior to transarterial chemoembolization as adjuvant therapy after narrow-margin hepatectomy in patients with hepatocellular carcinoma: A single-center prospective randomized study

Published:2024-03-15 Issue:1 Volume:409 Page:
ISSN:1435-2451
Container-title:Langenbeck's Archives of Surgery
language:en
Short-container-title:Langenbecks Arch Surg

Author:

Bai Tao,Tang Zhi-hong,Wang Xiao-bo,Chen Jie,Ye Jia-zhou,Lu Shao-long,Wei Meng,Wu Fei-xiang,Li Le-qun

Funder

Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Ministry of Education

Key Laboratory of High-Incidence-Tumor Prevention and Treatment of the Ministry of Education

Guangxi Medical University Training Program for Distinguished Young Scholars

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00423-024-03249-4.pdf

Reference31 articles.

1. Feng R, Su Q, Huang X, Basnet T, Xu X, Ye W (2023) Cancer situation in China: what does the China cancer map indicate from the first national death survey to the latest cancer registration? Cancer Commun (Lond) 43(1):75–86

2. Torimura T, Iwamoto H (2022) Treatment and the prognosis of hepatocellular carcinoma in Asia. Liver Int 42(9):2042–2054

3. Goh BKP, Chua DW, Koh YX, Tan EK, Kam JH, Teo JY et al (2021) Continuous improvements in short and long-term outcomes after partial hepatectomy for hepatocellular carcinoma in the 21st century: single institution experience with 1300 resections over 18 years. Surg Oncol 38:101609

4. Bruix J, Takayama T, Mazzaferro V, Chau GY, Yang J, Kudo M et al (2015) Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial. Lancet Oncol 16(13):1344–1354

5. Shi C, Li Y, Geng L, Shen W, Sui C, Dai B, Lu J, Pan M, Yang J (2022) Adjuvant stereotactic body radiotherapy after marginal resection for hepatocellular carcinoma with microvascular invasion: a randomised controlled trial. Eur J Cancer 166:176–184